Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Dopamine Agonists in Type 2 Diabetes - Vivian A. Fonseca

Dopamine Agonists in Type 2 Diabetes

Lehr- oder Lernkarte
2010
Oxford University Press Inc
978-0-19-977351-0 (ISBN)
CHF 10,95 inkl. MwSt
  • Titel ist leider vergriffen;
    keine Neuauflage
  • Artikel merken
This portable, ultra concise and up-to-date brochure provides key clinical insight as well as dosing and administration guidelines for newly FDA-approved dopamine agonist therapy for Type 2 diabetes.
Diabetes is the most prevalent metabolic disorder in the world. With many types of therapies available, including the mainstay insulin, the disease is manageable in most people. However, current anti-diabetes medications act primarily on peripheral end organs to regulate glucose and insulin levels. Dopamine agonist therapy, which targets the neuroendocrine patterns associated with insulin resistance, is a novel approach for diabetes treatment. Part of the Oxford American Pocket Cards series, this portable, ultra-concise and up-to-date brochure provides key clinical insight as well as dosing and administration guidelines for newly FDA-approved dopamine agonist therapy for Type 2 diabetes. To purchase this product, please contact U.S. Medical Sales at MedSales@oup.com
Erscheint lt. Verlag 15.9.2011
Reihe/Serie Oxford American Pocket Cards
Verlagsort New York
Sprache englisch
Gewicht 10 g
Themenwelt Medizinische Fachgebiete Innere Medizin Diabetologie
ISBN-10 0-19-977351-3 / 0199773513
ISBN-13 978-0-19-977351-0 / 9780199773510
Zustand Neuware
Informationen gemäß Produktsicherheitsverordnung (GPSR)
Haben Sie eine Frage zum Produkt?